|
Neonatal Intensive Care Drug Manual
|
| bet | 382/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Preparation/Dilution
|
400 microgram/mL
|
Administration
|
Use undiluted.
Intravenous (IV) bolus at proximal cannula site.
Intramuscular (IM).
|
Monitoring
|
Continuous cardiorespiratory monitoring is required.
Resuscitation facilities must be readily available.
|
Contraindications
|
Naloxone is contraindicated in persons known to be hypersensitive to it.
|
Precautions
|
Naloxone should not be administered to babies whose mothers are known or suspected to be addicted to opioids.
The duration of action of naloxone is short, particularly after intravenous administration and subsequent observation of the infant should be instituted.
|
Drug Interactions
|
Naloxone reverses the analgesic and other effects of opioid agonists.
|
|
|
| |
